Literature DB >> 13926101

The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report.

A M VINEBERG, R S CHARI, R PIFARRE, C MERCIER.   

Abstract

Twenty-five dogs were exposed to gradual coronary occlusion by placing Ameroid constrictors around the origins of the left circumflex and anterior descending coronary arteries. Previous experiments have demonstrated that these constrictors absorb water and, over a period of three weeks, narrow the cross-sectional area of the two arteries to 50% or less, and consequently cause the death of 80% of the experimental animals. Twelve of the 25 animals were fed 50 mg. of Persantin three times a day by mouth commencing one day before the operative procedure. Determinations of the concentration of the drug in the blood revealed a level consistent with that obtained in humans after the administration of therapeutic doses. Eleven of the 13 control animals died in the three-month experimental period while only six of the 12 treated animals expired. Injections of Schlesinger mass in all animals dying or killed following the experimental period demonstrated that Persantin significantly accelerated the development of intercoronary anastomoses in the treated group, and in the surviving animals produced a rich anastomotic network much in excess of that seen in the surviving animals in the control series that were exposed to hypoxia alone. On the basis of these experimental findings, it is suggested that Persantin may favourably alter the prognosis of many patients with coronary artery disease.

Entities:  

Keywords:  CORONARY DISEASE/experimental; VASODILATOR AGENTS/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13926101      PMCID: PMC1849506     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Pathogenesis of coronary disease in American soldiers killed in Korea.

Authors:  W F ENOS; J C BEYER; R H HOLMES
Journal:  J Am Med Assoc       Date:  1955-07-16

2.  The effect of persantin on coronary flow and cardiac dynamics.

Authors:  E C ELLIOT
Journal:  Can Med Assoc J       Date:  1961-08-26       Impact factor: 8.262

3.  Studies with a new coronary vasodilator drug: persantin.

Authors:  D KINSELLA; W TROUP; M McGREGOR
Journal:  Am Heart J       Date:  1962-02       Impact factor: 4.749

4.  [5,4-d] pyrimidine on the circulation of experimental myocardial infarct and healthy myocardium].

Authors:  M KIESE; G LANGE; K RESAG
Journal:  Z Gesamte Exp Med       Date:  1960

5.  Effects of Persantin (RA8), a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog.

Authors:  J W WEST; S BELLET; U C MANZOLI; O F MUELLER
Journal:  Circ Res       Date:  1962-01       Impact factor: 17.367

  5 in total
  7 in total

1.  Controlled trial of dipyridamole in cerebral vascular disease.

Authors:  J Acheson; G Danta; E C Hutchinson
Journal:  Br Med J       Date:  1969-03-08

2.  [The effect of coronary dilator drugs on oxygen pressure and blood supply of the dog myocardium, normal and with coronary insufficiency].

Authors:  R Kadatz
Journal:  Arch Kreislaufforsch       Date:  1969 Mar-Apr

3.  [Intravital coronarography from the surgical viewpoint].

Authors:  A Düx
Journal:  Langenbecks Arch Chir       Date:  1969

4.  Inhibition of adrenergic cardiopathies by drugs. I. Dipyridamole.

Authors:  F W Eichbaum; S Zyngier; E P De Campos
Journal:  Arch Kreislaufforsch       Date:  1970 May-Jun

5.  [Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].

Authors:  W Rudolph; L Meixner; H J Künzig
Journal:  Klin Wochenschr       Date:  1967-04-01

6.  Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.

Authors:  L C Becker
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

Review 7.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.